Rubius Therapeutics Raises $100 Million in Crossover Financing Post author:Sam Post published:February 28, 2018 Post category:BioPharma Rubius Therapeutics has closed on an oversubscribed $100 million crossover financing. Source: BioSpace You Might Also Like These 3 Biotechs Could Lead the Next Biotech Boom May 21, 2017 Sinovac Biotech Ltd. Reports Announces Filing Extension For 2016 Annual Report April 30, 2017 Amazon Yanks Pharma License App in Maine December 5, 2017
